KR20050095605A - 폴리펩티드의 정제 - Google Patents

폴리펩티드의 정제 Download PDF

Info

Publication number
KR20050095605A
KR20050095605A KR1020057012831A KR20057012831A KR20050095605A KR 20050095605 A KR20050095605 A KR 20050095605A KR 1020057012831 A KR1020057012831 A KR 1020057012831A KR 20057012831 A KR20057012831 A KR 20057012831A KR 20050095605 A KR20050095605 A KR 20050095605A
Authority
KR
South Korea
Prior art keywords
polypeptide
homogenate
lactate
broth
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020057012831A
Other languages
English (en)
Korean (ko)
Inventor
필립 엠. 레스터
조세핀 퍼슨
Original Assignee
제넨테크, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제넨테크, 인크. filed Critical 제넨테크, 인크.
Publication of KR20050095605A publication Critical patent/KR20050095605A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR1020057012831A 2003-01-09 2004-01-08 폴리펩티드의 정제 Ceased KR20050095605A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43941803P 2003-01-09 2003-01-09
US60/439,418 2003-01-09

Publications (1)

Publication Number Publication Date
KR20050095605A true KR20050095605A (ko) 2005-09-29

Family

ID=33299572

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020057012831A Ceased KR20050095605A (ko) 2003-01-09 2004-01-08 폴리펩티드의 정제

Country Status (18)

Country Link
US (2) US7169908B2 (cg-RX-API-DMAC7.html)
EP (1) EP1581644B1 (cg-RX-API-DMAC7.html)
JP (1) JP2006517415A (cg-RX-API-DMAC7.html)
KR (1) KR20050095605A (cg-RX-API-DMAC7.html)
CN (1) CN100467611C (cg-RX-API-DMAC7.html)
AT (1) ATE364092T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004230670B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0406470A (cg-RX-API-DMAC7.html)
CA (1) CA2511946A1 (cg-RX-API-DMAC7.html)
DE (1) DE602004006831T2 (cg-RX-API-DMAC7.html)
DK (1) DK1581644T3 (cg-RX-API-DMAC7.html)
ES (1) ES2287687T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA05007378A (cg-RX-API-DMAC7.html)
NZ (1) NZ540895A (cg-RX-API-DMAC7.html)
PL (1) PL377653A1 (cg-RX-API-DMAC7.html)
RU (1) RU2337968C2 (cg-RX-API-DMAC7.html)
WO (1) WO2004092393A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200504990B (cg-RX-API-DMAC7.html)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE298251T1 (de) 1998-08-06 2005-07-15 Mountain View Pharmaceuticals Peg-uricase konjugate und verwendung davon
ATE489400T1 (de) * 2002-09-06 2010-12-15 Genentech Inc Verfahren zur proteinextraktion
TWI418564B (zh) * 2005-04-11 2013-12-11 沙凡特藥品公司 利用陽離子界面活性劑之蛋白質純化
KR20080009111A (ko) 2005-04-11 2008-01-24 새비언트 파마수티컬즈 인크. 유레이트 옥시다아제의 변이형 및 이의 용도
MY143274A (en) 2005-12-22 2011-04-15 Genentech Inc Recombinant production of heparin binding proteins
KR101288027B1 (ko) * 2006-04-12 2013-07-22 새비언트 파마수티컬즈 인크. 양이온 계면활성제를 이용한 단백질 정제 방법
FR2902799B1 (fr) 2006-06-27 2012-10-26 Millipore Corp Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide
CN101506222B (zh) 2006-07-14 2013-10-02 健泰科生物技术公司 重组蛋白的重折叠
US8163886B2 (en) 2006-12-21 2012-04-24 Emd Millipore Corporation Purification of proteins
US8569464B2 (en) 2006-12-21 2013-10-29 Emd Millipore Corporation Purification of proteins
WO2008140615A2 (en) * 2006-12-21 2008-11-20 Novozymes, Inc. Modified messenger rna stabilizing sequences for expressing genes in bacterial cells
US8362217B2 (en) 2006-12-21 2013-01-29 Emd Millipore Corporation Purification of proteins
RU2474585C2 (ru) 2007-01-22 2013-02-10 Дженентек, Инк. Осаждение и очистка белков полиэлектролитами
EP2586788B1 (en) 2007-07-09 2017-11-29 Genentech, Inc. Prevention of disulfide bond reduction during recombinant production of polypeptides
US7887821B2 (en) * 2007-12-20 2011-02-15 Alk-Abello A/S Process for producing an allergen extract
WO2009151514A1 (en) 2008-06-11 2009-12-17 Millipore Corporation Stirred tank bioreactor
GB0818228D0 (en) * 2008-10-06 2008-11-12 Avecia Biolog Ltd Purification process
EP2337787A1 (en) * 2008-10-17 2011-06-29 Percivia LLC. Clarification process
DK2370561T3 (da) 2008-12-16 2019-10-21 Emd Millipore Corp Omrøringstankreaktor og fremgangsmåde
JP2012531596A (ja) 2009-06-25 2012-12-10 サヴィエント・ファーマシューティカルズ・インコーポレイテッド Peg化ウリカーゼ療法における血清尿酸をモニタリングすることにより注入反応の危険性および抗体媒介性効果消失を予測するための方法およびキット
US8709757B2 (en) * 2010-02-01 2014-04-29 Digna Biotech, S.L. Method for producing interferon alpha 5
AU2011214316B2 (en) * 2010-02-12 2015-07-02 Laboratorios Leti, S.L. Process for producing an allergen extract
BR112012020964B8 (pt) * 2010-03-10 2021-08-24 Hoffmann La Roche método para produzir uma imunoglobulina da subclasse igg1 ou igg4
JO3131B1 (ar) 2010-04-27 2017-09-20 Glaxosmithkline Llc مركبات كيميائية
CN102892791B (zh) 2010-05-17 2017-05-17 Emd密理博公司 用于纯化生物分子的刺激响应性聚合物
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
DE102011001743A1 (de) * 2011-04-01 2012-10-04 Technische Universität Dortmund Verfahren zur Trennung/Reinigung von Biomolekühlen
SI2766397T1 (sl) 2011-10-11 2018-09-28 F. Hoffmann-La Roche Ag Izboljšano sestavljanje bispecifičnih protiteles
CN102443055B (zh) * 2011-10-26 2017-07-28 浙江海正药业股份有限公司 一种重组人肿瘤坏死因子相关凋亡诱导配体的纯化工艺
WO2013180648A1 (en) * 2012-05-31 2013-12-05 Agency For Science, Technology And Research Methods for use of mixed multifunctional surfaces for reducing aggregate content in protein preparations
CN102701501A (zh) * 2012-06-26 2012-10-03 天津市津华盛生物科技有限公司 工业乳酸链球菌素废水综合利用的方法
US9988419B2 (en) * 2013-02-06 2018-06-05 Agency For Science, Technology And Research Protein purification methods
SG10201610955SA (en) * 2013-02-26 2017-02-27 Agency Science Tech & Res Protein purification in the presence of nonionic organic polymers and electropositive surfaces
WO2014133459A1 (en) 2013-02-28 2014-09-04 Agency For Science, Technology And Research Chromatographic purification of antibodies from chromatin-deficient cell culture harvests
CN105008384A (zh) * 2013-02-28 2015-10-28 新加坡科技研究局 在高电导率下在非离子性有机聚合物的存在下的蛋白质纯化
US9914770B2 (en) * 2013-04-30 2018-03-13 Intas Pharmaceuticals Ltd Cloning, expression and purification method for the preparation of ranibizumab
WO2015166037A1 (en) 2014-04-30 2015-11-05 Novozymes A/S Method for reducing the dna content of a fermentation broth
CN116637177A (zh) 2016-11-11 2023-08-25 好利恩治疗美国公司 泼尼松和尿酸酶分子的组合疗法及其用途
CN108333263A (zh) * 2017-01-20 2018-07-27 北京蛋白质组研究中心 一种尿蛋白制备方法及尿蛋白质组的检测方法
TW201927335A (zh) * 2017-10-02 2019-07-16 美商拜耳保健有限責任公司 防止雙硫鍵於細胞培養收集物中還原之方法
US20190194298A1 (en) 2017-12-22 2019-06-27 Regeneron Pharmaceuticals, Inc. System and method for characterizing drug product impurities
CN111363024A (zh) * 2018-12-26 2020-07-03 深圳翰宇药业股份有限公司 多肽的纯化方法
WO2020160325A1 (en) 2019-01-30 2020-08-06 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
WO2020247983A1 (en) * 2019-06-05 2020-12-10 Viome, Inc. Sample collection methods and devices
ES3036955T3 (en) 2020-04-15 2025-09-26 Genentech Inc Copper loss mitigation
CN112708566A (zh) * 2021-01-25 2021-04-27 西南林业大学 一种黑曲霉生产胞外多聚物的优化培养基及培养方法
CN114774500A (zh) * 2022-04-26 2022-07-22 成都蜀星饲料有限公司 多肽及制备方法、有机复合微量元素及制备方法
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL34079A (en) * 1969-04-01 1973-02-28 Upjohn Co Purification of ypsilon-globulins
US3607857A (en) * 1970-03-03 1971-09-21 Upjohn Co Process of removing acrinol from gamma globulin using siliceous material such as silica gel
US3903254A (en) * 1971-07-23 1975-09-02 Upjohn Co Separation of erythrocyte stroma from lysing medium and hemoglobin with acrinol
DE2308013A1 (de) * 1973-02-17 1974-09-12 Behringwerke Ag Katalasearme glucoseoxidase und verfahren zu ihrer gewinnung
JPS519035B2 (cg-RX-API-DMAC7.html) 1973-10-31 1976-03-23
SU944580A1 (ru) 1980-02-07 1982-07-23 Кировский научно-исследовательский институт переливания крови Способ получени поверхностного антигена гепатита В
CA1237998A (en) * 1984-04-14 1988-06-14 Akihiro Ginnaga Method for purification of filamentous hemagglutinin
JPS60258127A (ja) * 1984-06-04 1985-12-20 Green Cross Corp:The B型肝炎ワクチンの製造方法
DE3580590D1 (de) * 1985-05-29 1990-12-20 Green Cross Corp Herstellungsverfahren fuer heterogene proteine.
DE3581412D1 (de) * 1985-07-16 1991-02-21 Green Cross Corp Verfahren zur herstellung von heteroproteinen.
DE3604947A1 (de) 1986-02-17 1987-08-20 Biotest Pharma Gmbh Verfahren zur herstellung eines immunglobulinhaltigen praeparates und dessen verwendung zur prophylaxe und therapie von aids
FR2600078B1 (fr) 1986-06-12 1989-07-13 Merieux Inst Procede de preparation de facteur xiii a partir du placenta
DE3929504A1 (de) * 1989-09-06 1991-03-07 Behringwerke Ag Verfahren zur reinigung von plasminogen-aktivator-inhibitor 2 (pai-2)
DE4030264A1 (de) * 1990-09-25 1992-04-23 Hoechst Ag Verfahren zur herstellung gereinigter glycolipide durch membrantrennverfahren
GB9215540D0 (en) 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
US5861263A (en) * 1992-10-20 1999-01-19 Universidad Autonoma De Nuevo Leon Preparation of preserved entamoeba histolytica antigens without enzymatic inhibitors and their use in immunological methods
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US5760189A (en) 1995-06-02 1998-06-02 Genetics Institute, Inc. Protein recovery & purification methods
US5714583A (en) 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
US6121428A (en) 1997-06-13 2000-09-19 Genentech, Inc. Protein recovery
JPH11341947A (ja) * 1998-06-02 1999-12-14 Yakult Honsha Co Ltd 発酵管理方法
US6156514A (en) * 1998-12-03 2000-12-05 Sunol Molecular Corporation Methods for making recombinant cells
DE60116733T2 (de) * 2000-01-20 2006-11-02 Regents Of The University Of Minnesota, Minneapolis Peptide mit antibakterieller wirkung

Also Published As

Publication number Publication date
AU2004230670A1 (en) 2004-10-28
MXPA05007378A (es) 2005-11-23
DE602004006831D1 (de) 2007-07-19
DK1581644T3 (da) 2007-10-08
DE602004006831T2 (de) 2008-02-14
ATE364092T1 (de) 2007-06-15
NZ540895A (en) 2007-03-30
ES2287687T3 (es) 2007-12-16
AU2004230670B2 (en) 2010-11-25
RU2337968C2 (ru) 2008-11-10
EP1581644B1 (en) 2007-06-06
CN1759186A (zh) 2006-04-12
WO2004092393A1 (en) 2004-10-28
BRPI0406470A (pt) 2005-12-06
US20070077625A1 (en) 2007-04-05
CN100467611C (zh) 2009-03-11
US7169908B2 (en) 2007-01-30
PL377653A1 (pl) 2006-02-06
ZA200504990B (en) 2006-08-30
US7579448B2 (en) 2009-08-25
US20050037456A1 (en) 2005-02-17
RU2005125210A (ru) 2006-01-10
CA2511946A1 (en) 2004-10-28
JP2006517415A (ja) 2006-07-27
EP1581644A1 (en) 2005-10-05

Similar Documents

Publication Publication Date Title
NZ540895A (en) Purification of polypeptides with ethacridine lactate
KR100968664B1 (ko) 항체 발현 및 조립을 위한 시스템
AU2020398830B2 (en) Anti-VEGF protein compositions and methods for producing the same
KR100879194B1 (ko) 원핵생물에 의해 제조된 항체 및 이의 용도
KR102036399B1 (ko) 단백질 발현용 재조합 박테리아 숙주 세포
RU2441071C2 (ru) Способы получения растворимых многопроходных трансмембранных белков
CZ304484B6 (cs) Bakteriální hostitelské kmeny a způsob tvorby polypeptidu
IL175367A (en) Anti-cd-20 type II antigen-binding molecule and its use in the manufacture of a drug to treat b-cell proliferative disorders or autoimmune diseases
JP2021078502A (ja) 超精製DsbA及びDsbC、ならびにそれらの作製及び使用方法
CN107636012B (zh) 蛋白质纯化方法
CN105392889A (zh) 表达方法
KR102096678B1 (ko) 재조합 단백질을 위한 개선된 수확 작업
AU2019215125B2 (en) System and method for characterizing protein dimerization
TW202413404A (zh) 抗cd20抗體組成物
HK40016915A (en) Recombinant bacterial host cell for protein expression
JP2024517701A (ja) 組換え生産タンパク質の低分子量種を低減させる方法
HK1247624A1 (en) Method for protein purification
HK1247624B (en) Method for protein purification
HK1207120B (en) Improved harvest operations for recombinant proteins
HK1176946A1 (zh) 纯化免疫球蛋白溶液的方法

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20050708

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20081226

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20110120

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20110622

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20110120

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I